Stay updated on Nab-Paclitaxel/Gemcitabine±Olaratumab in Metastatic Pancreatic Ca Clinical Trial
Sign up to get notified when there's something new on the Nab-Paclitaxel/Gemcitabine±Olaratumab in Metastatic Pancreatic Ca Clinical Trial page.

Latest updates to the Nab-Paclitaxel/Gemcitabine±Olaratumab in Metastatic Pancreatic Ca Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedRevision label updated to v3.5.0 (replacing v3.4.3).SummaryDifference0.0%

- Check25 days agoChange DetectedSite revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check54 days agoChange DetectedThe page shows a revision label update from v3.4.1 to v3.4.2, which does not modify study details or user-facing functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check61 days agoChange DetectedRevision from v3.4.0 to v3.4.1 appears to be a minor site version update with no changes to study data, eligibility criteria, or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check68 days agoChange DetectedUI and metadata updates include a new Show glossary control and updated labels: 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data' capitalization, and a revision note 'Revision: v3.4.0'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check82 days agoChange Detected- The page revision was updated from v3.3.3 to v3.3.4. No substantive changes to study details or related information.SummaryDifference0.0%

Stay in the know with updates to Nab-Paclitaxel/Gemcitabine±Olaratumab in Metastatic Pancreatic Ca Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nab-Paclitaxel/Gemcitabine±Olaratumab in Metastatic Pancreatic Ca Clinical Trial page.